Medplus Health Services corrects inadvertent investor presentation filing

0 min read     Updated on 22 Jul 2026, 10:52 PM
scanx
Reviewed by
Jubin VScanX News Team
AI Summary

Medplus Health Services Limited informed the National Stock Exchange of India Limited and BSE Limited to ignore an inadvertent filing of an investor presentation dated July 21, 2026, which included an incorrect attachment. The company confirmed that the correct document has been filed subsequently. Stakeholders were requested to rely on the revised filing.

powered bylight_fuzz_icon
46286532

*this image is generated using AI for illustrative purposes only.

Medplus Health Services Limited has requested the National Stock Exchange of India Limited and BSE Limited to disregard an inadvertent filing of an investor presentation made on July 21, 2026. The company stated that the filing contained an unintended attachment due to an error. The correct investor presentation has since been submitted to both exchanges, and stakeholders are advised to refer to this subsequent filing.

The erroneous submissions were made on the evening of July 21, 2026. The filing on the National Stock Exchange of India Limited occurred at 19:42:39 PM, while the submission to BSE Limited was recorded at 19:43:07 PM. Both filings were made under the subject "Investor Presentation."

The company clarified that the original filing and its attachment should be ignored. The communication was addressed to the Listing Departments of both exchanges and signed by Shrenik Soni, Company Secretary & Compliance Officer of Medplus Health Services Limited.

Stock Exchange Filing Details
National Stock Exchange of India Limited Subject: Investor Presentation
Date: 21 July 2026
Time: 19:42:39 PM
BSE Limited Subject: Investor Presentation
Date: 21 July 2026
Time: 19:43:07 PM

Historical Stock Returns for Medplus Health Services

1 Day5 Days1 Month6 Months1 Year5 Years
-1.86%-6.25%-19.38%-22.80%-19.33%-41.44%

What specific discrepancies existed between the erroneous and corrected investor presentations?

Will this filing error trigger any regulatory scrutiny or penalties from the exchanges?

How might the market react to the corrected presentation regarding Medplus's future outlook?

Medplus Health Services
View Company Insights
View All News
like18
dislike

MedPlus appoints Shrenik Soni as Company Secretary

1 min read     Updated on 21 Jul 2026, 09:44 PM
scanx
Reviewed by
Riya DScanX News Team
AI Summary

MedPlus Health Services Ltd has appointed Mr. Shrenik Soni as Company Secretary and Compliance Officer (Key Managerial Personnel) effective July 21, 2026. The Board approved the appointment based on the recommendation of the Nomination and Remuneration Committee. Mr. Soni, a Fellow Member of ICSI with an MBA, has over nine years of experience in corporate governance and previously worked with HRV Pharma, SUVEN Life Sciences, and DUKES Group.

powered bylight_fuzz_icon
46194101

*this image is generated using AI for illustrative purposes only.

Medplus Health Services appointed Mr. Shrenik Soni as its Company Secretary and Compliance Officer (Key Managerial Personnel) effective July 21, 2026. The appointment was approved by the Board of Directors on the recommendation of the Nomination and Remuneration Committee. Mr. Soni is a Fellow Member of the Institute of Company Secretaries of India (ICSI) and holds an MBA in dual specialization from Osmania University.

Mr. Shrenik Soni brings over nine years of experience in corporate secretarial, legal, and compliance functions across sectors such as pharmaceuticals, manufacturing, and retail. His previous roles include handling board processes, fundraising, ESOPs, regulatory interfaces, and corporate restructuring. Before joining MedPlus, he was associated with HRV Pharma, SUVEN Life Sciences, and DUKES Group as Company Secretary.

The disclosure was made pursuant to Regulation 30 read with Schedule III of Part A of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The company has enclosed the necessary details as per the SEBI Master Circular dated January 30, 2026. The appointment is effective immediately from the date of the board meeting.

Particulars Details
Name of the KMP Mr. Shrenik Soni (M. No.: F12400)
Reason for Change Appointment as Company Secretary and Compliance Officer
Date of Appointment July 21, 2026
Qualification Fellow Member of ICSI, MBA
Previous Experience HRV Pharma, SUVEN Life Sciences, DUKES Group

Historical Stock Returns for Medplus Health Services

1 Day5 Days1 Month6 Months1 Year5 Years
-1.86%-6.25%-19.38%-22.80%-19.33%-41.44%

How will Mr. Soni's prior experience in the pharmaceutical sector influence MedPlus's regulatory compliance strategy?

Does this appointment signal any upcoming corporate restructuring or capital raising initiatives for the company?

What are the strategic priorities for the compliance function under the new leadership given the evolving SEBI regulations?

Medplus Health Services
View Company Insights
View All News
like16
dislike

More News on Medplus Health Services

1 Year Returns:-19.33%